From Sample to Insight

Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase

QIAGEN reports results for first quarter 2018

QIAGEN announces FDA approval of PartoSure

QIAGEN announces European launch of QIAstat-Dx, a next generation platform for syndromic insights

QIAGEN launches AdnaTest liquid biopsy kits in prostate and lung cancer

QIAGEN’s QuantiFERON-TB® Gold Plus gains endorsement for latent tuberculosis screening in immigration

QIAGEN and Natera partner to develop cutting-edge genetic testing assays for use on QIAGEN’s GeneReader NGS System

QIAGEN launches CE-IVD assay to detect Trichomonas vaginalis in both female and male patients on the QIAsymphony RGQ platform

QIAGEN opens Shared Services Center in Taguig City, Manila

QIAGEN welcomes WHO’s new global guidelines on latent TB screening